Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$VPRB 7m MICRO FLOAT MJ stock! Small market cap!
https://investorshub.advfn.com/VPR-Brands-LP-VPRB-28012/
http://www.otcmarkets.com/stock/VPRB/profile
PSNX .0003 getting chipped away here!
CBIS up 9.3 % going to .20 area soon
Mining stocks will be winners this year..any picks out here ?
FUSZ .13. 8K OUT!! Deal with Oracle! The REAL DEAL!
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12456078
CBIS up 8 % so far gonna break the .13 52 week high soon
AZFL .0006's hitting -- CBD product launch imminent!!!
$BAYP .0001x .0002
http://www.weedwiser.com
https://www.otcmarkets.com/stock/BAYP/news
TWITTER PAGE..
https://twitter.com/BayportBAYP
Amfil Technologies Inc. Provides General Overview on New Year 2018's Immediate and On-Going Focus for the Company
TORONTO, ON, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Amfil Technologies Inc. (OTC Pink: AMFE) is pleased to provide a general overview of the company’s immediate focus, goals, and strategic initiatives for calendar 2018.
Continuing from the achievements and growth realized throughout 2017, the company is positioned to significantly expand operations as we enter the new year. Shareholders can expect growth and expansion to continue as we execute on the company’s proven business models and growth strategies for each respective subsidiary and division.
Key initiatives to expect include:
GRO3
Shareholders can expect significant developments throughout 2018 from the GRO3 and overall medical marijuana initiative. As legalization continues to spread throughout the United States, and as legalization is implemented nationally in Canada this year, the company is well positioned to develop a significant market share in the industry by ensuring that industry products are meeting regulatory requirements.
The company will continue working alongside our Canadian cultivation partners, and will complete the rollout of the GRO3 / RotoGRO technologies in their new facility, which is currently under construction.
The company will set up a showroom in California, showcasing the product lines for the Californian market as we anticipate it becoming a large focus of the company’s sales and marketing efforts. Key personnel residing in California have been hired and will be handed the existing leads and ongoing discussions the company is undertaking with Californian cultivators in order to close the leads and realize sales. More info on this initiative coming shortly.
The company will continue to work with existing contacts and other interested parties on their schedules in order to accommodate and facilitate their roll-out needs, and the introduction of the technology into their facilities. 2017 laid major groundwork in the industry that this subsidiary should be able to capitalize on it throughout 2018, converting interest into purchase orders.
Corporate
Company Audit: We expect this process to be completed, submitted, and announced this month. Following the audit completion, the company will immediately seek to up-list to the OTCQB or OTCQX, dependent upon share price and negotiation with the exchange.
Once up-listed, the company will announce the spinoff date of the Interloc-Kings Inc. subsidiary, which in turn will initiate the dividend date, allowing existing shareholders to receive shares in the new public entity.
Natural Stuff Inc.
The addition of new brands and products to promote distribution expansion.
Expansion of the sales force to continue to facilitate the division’s growth.
Expansion of the distribution facility to support growing demand from small businesses, large national corporations, and big box retailers.
Framework development for the distribution of infused products.
Snakes & Lattes Inc.
Following on the opening of Snakes & Lattes Midtown, the leadership team intends to shift primary focus to the franchising initiative and to the US based expansion strategy. Hamilton and Kitchener/Waterloo area franchises were sold in 2017, and management is in discussions with many other interested parties for franchising in the United States and Canada. These efforts are expected to contribute to the company’s bottom line throughout 2018.
Other developments include:
Corporate support for Hamilton and Kitchener/Waterloo franchisees as buildout occurs.
Expected to open a US distribution center.
Expected to open Chicago as the U.S. corporate headquarters, and first U.S. corporate store location.
Expected to approve and open multiple US franchise locations.
Expected to have self-published game title(s)
Expected additional large exclusive distribution rights for high-demand game titles for multiple global markets.
Expected to receive exclusive rights to games being developed by consistently successful designers with existing high-demand titles.
Complete overhaul of online company presence, while adding numerous additional titles for purchase through the in-house distribution line, and new branded merchandise.
Hosting of a shareholder appreciation night in Toronto at Snakes & Lattes Midtown in early 2018. The exact date will be announced with three weeks prior notice, to ensure ample time for shareholders to make travel and/or accommodation arrangements.
This is just a broad scope of previously publicized initiatives and events to expect in the coming weeks/months. There are also a number of exciting developments progressing behind the scenes which will significantly contribute to the company’s bottom line moving forward. The details will be released to the public when appropriate.
The company remains steadfast in its commitment to deliver the maximum value back to our shareholders as we continue to accelerate into the new year. Significant increases in revenue contributions from all subsidiaries is expected throughout 2018, as the company continues to expand its operational focus and extend its reach into new industry sectors and geographical markets.
“We have full expectations that the company will continue its upwards trajectory throughout 2018 and beyond, at a rate unprecedented for the company,” stated Roger Mortimer, CEO. “I would like to thank our shareholders for their support, and reaffirm that our progress and expansion is showing no signs of slowing down in the foreseeable future. Stay tuned, as 2018 is sure to be the biggest year on record!”
A number of updates can be expected from Amfil Technologies Inc. and its subsidiaries in the near future.
For more information regarding the company, please visit www.amfiltech.com and follow us on Twitter for further updates @AmfilTech.
For more information on Snakes & Lattes Inc. please visit www.snakesandlattes.com
For more information on GRO3, please visit http://gro3systems.com/
About Us:
Amfil Technologies, Inc. is the parent company to three wholly owned subsidiaries.
1). Snakes & Lagers Inc. holds the trade name and is the owner of Snakes & Lattes Inc. which currently operates a 6,000 sq. ft. and a 7,500 sq. ft. tabletop gaming bar and cafe located in Toronto, Ontario that brought in over $7M CAD in revenue last year. It is in the process of opening a third location at 10,000 sq. ft., the largest to date. Snakes & Lagers Inc. is also the procurement officer of all existing and future Snakes & Lattes Inc. franchises and has the exclusive rights to sell franchise locations globally. Snakes & Lattes Inc. was the first board game bar and cafe in North America, is believed to be the largest in the world and have the largest circulating public library of board games in North America for customers to choose from. Snakes & Lattes Inc. currently has a 100+ member staff and recently acquired the exclusive distribution rights throughout Canada for some of the most popular board games in the world. BlogTO.com recently named Snakes & Lattes Inc. the best late night cafe in Toronto and has also been named the best fulfillment house in Canada by Jamey Stegmaier, the most influential blogger within the board game fulfillment sphere. For more information on Snakes & Lattes Inc. feel free to visit the website at www.snakesandlattes.com.
2). The EcoPr03 GRO3 Antimicrobial System was jointly developed between Amfil Tech and A.C.T.S. Inc. which recently rebranded its technology under Advanced Ozone Integration as an extension of the existing ozone technology being utilized in the food and beverage industry and integrated by A.C.T.S. into companies such as Pepsi, Nestle, Sysco, Sun Pacific and many others. The system is a triple-function sanitization unit capable of naturally eliminating 99.9% of water and airborne pathogens and the typically problematic pests that wreak havoc for cultivators (like aphids, whiteflies and spider mites), as well as bacteria, fungus, microbes and mold on surfaces, all without chemicals. The unit can also constantly regulate a given facility's water supply, oxygenating the water and maintaining a consistent PPM infusion of ozone that prevents the formation of algae, bacteria or mold (allowing for comprehensive water recycling), simultaneously removing the need to use pesticides and/or dangerous, often carcinogenic products to treat production problems, as is common throughout the industry today. This environmentally-friendly solution also eliminates odors, while slightly reducing the air temperature, lowering energy consumption by the HEPA filtration and HVAC systems and could potentially allow for a facilities process to be labeled certified organic in the U.S.A. when the crop is no longer considered illegal on the federal level, otherwise "Clean Green" or "Certified Kind" in the meantime. The EcoPr03 GRO3 Antimicrobial System recently passed product review by a registered USDA certifying agent for use in California as well as Pennsylvania and surrounding states. More information on this product line can be found on the www.gro3systems.com website or on twitter @GRO3Systems.
3). Interloc-Kings Inc. is a hardscape construction company servicing the Greater Toronto Area. This subsidiary is an authorized Unilock installer, Unilock being, North America's premier manufacturer of concrete interlocking paving stones and segmental wall products. Interloc-Kings Inc. has an A+ Rating with the Better Business Bureau (BBB) and a 10/10 rating on homestars.com. Specializing in stone and wood installations between $5,000 and $150,000 per project, Interloc-Kings Inc. has quickly become a top, high quality installation company of outdoor living areas in the GTA. More information on this subsidiary can be found at the website www.interloc-kings.com.
Safe Harbor Statement
This news release contains statements that involve expectations, plans or intentions (such as those relating to future business or financial results, new features or services, or management strategies) and other factors discussed from time to time in the Company's OTC Market or Securities and Exchange Commission filings. These statements are forward-looking and are subject to risks and uncertainties, so actual results may vary materially. You can identify these forward-looking statements by words such as "may," "should," "expect," "anticipate," "believe," "estimate," "confident," "intend," "plan" and other similar expressions. Our actual results, such as the Company's ability to finance, complete and consolidate acquisition of IP, assets and operating companies, could differ materially from those anticipated in these forward-looking statements as a result of certain factors not within the control of the company such as a result of various factors, including future economic, competitive, regulatory, and market conditions. The company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
Roger Mortimer
Amfil Technologies Inc.
Telephone: (647) 880-5887
Email: ir@amfiltech.com
Source: Amfil Technologies Inc.
© 2018 GlobeNewswire, Inc.
$WCTXF Intersects Numerous Commercial Grade Cobalt Zones at Teledyne Cobalt Property
https://finance.yahoo.com/news/lico-energy-metals-intersects-numerous-133000341.html
VANCOUVER, British Columbia, Jan. 3, 2018 /PRNewswire/ -- LiCo Energy Metals Inc. ("the Company" or LiCo") (LIC.V), (WCTXF) is pleased to report assay results for drill holes TE17-02 and TE17-03 completed on the Teledyne Cobalt Property, located 6 km northeast of Cobalt, Ontario.
A summary of the most significant results of the recent drill core assays are:
TE17-02 0.95% Co over 1.9 m from 143.0 to 144.9 m, incl. 2.58% Co over 0.60 m from 144.30 to 144.90 m
TE17-02 0.59% Co over 3.9 m from 156.0 to 159.9 m, incl. 2.22% Co over 0.60 m from 156.6 to 157.2 m
On the Teledyne Cobalt Property, the Company completed a total of 11 diamond drill holes totaling 2,200 m in the fall of 2017. The drilling has confirmed the cobalt mineralization on the Property which is consistent with historical grades and widths reported historically.
As reported on the Company's November 30th, 2017 news release, LiCo has recently completed its 2017 diamond drilling program on its Teledyne and Glencore Bucke Properties completing a total of 32 diamond drill holes, drilling 4,100 m of core. This exploration work satisfies both its flow-through financing obligations and the contractual obligations outlined in the recently acquired Glencore Bucke Property from Glencore plc of Baar Switzerland (GLEN.L). The overall drilling program has confirmed and extended the cobalt mineralization on each property and these results are consistent with historical grades and widths in the overall Cobalt Camp. As reported previously, visual cobalt camp style mineralization has been noted in every drill hole that the Company has logged.
$EPAZ announced today that the company’s new Android blockchain Bitcoin payment system, ZenaPay, is now available on the Play Store. https://finance.yahoo.com/news/epazz-zenapay-android-blockchain-bitcoin-140000698.html
News - 1 million market Cap / CBD.com website
$ONCI tweet out!! Huuuge
signature page of scully lemoine contract signed sealed and delivered . Between Scully, Capoli and USW the whole country is covered and we have over 100 salespeople representing our products just amazing $ONCI https://t.co/KMcVlRorZk
$FUSZ Signs Definitive Agreement With $ORCL:NYSE (Oracle Corp.).....This is Huge!
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12456078
GRCK News and Chart is primed!Grey Cloak Announces the Launch of CBD.co -- "The Cannabinoid Marketplace"
9:00 am ET January 3, 2018 (Globe Newswire) Print
Grey Cloak Tech, Inc. (OTCQB: GRCK) today announced that it has launched CBD.co, a marketplace of CBD products featuring suppliers and products. CBD.co is anticipated to become the definitive destination on the web for all things hemp and CBD, according to Patrick Stiles, Chief Executive Office of Grey Cloak Tech, Inc.
Stiles said, "The big online advertising companies like Amazon, Google and Facebook mostly refuse to allow CBD products on their platforms. This ultimately hurts consumers who are looking for reliable CBD products from brands they can trust.
"Additionally, countless CBD companies struggle every day to get their products in front of consumers because of the same advertising blockage.
"This is why we created CBD.co to solve this for the industry as a whole."
All of CBD.co's supplier partner brands must pass a strict quality control process. This includes investigating compliance and quality aspects of the products. They need to provide certificates of analysis (COA) and other materials to CBD.co in order to be listed on the site.
Products on CBD.co are divided into helpful categories. As of the date of its launch, CBD.co has the following categories: Pets, Skincare, CBD Oil, and Vaping.
These categories include products such as salves, gelcaps, CBD vapes, gummy bears, soap, cooling sticks, tinctures, nano CBD, liposomal delivery, pet products, lip balm, pet shampoos, dog treats, functional products for specific conditions, and CBD delivered in MCT or coconut oil. All with CBD or full spectrum hemp oil.
Additionally, CBD.co has launched an in-depth "CBD Learning Center" with content written by in-house health experts. It covers many different topics of CBD uses and education.
About Grey Cloak Tech, Inc.
Grey Cloak Tech (OTCQB: GRCK) is the parent company of CBD.co as well as Eqova Life Sciences, which is a practitioner line of CBD products sold exclusively to licensed medical professionals.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility," and "anticipate." The achievement or success of the matters covered by such forward-looking statements involves significant risks, uncertainties, and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K filed with the SEC on April 17, 2017 and future periodic reports filed with the SEC. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
For more information, visit http://www.greycloaktech.com. http://www.cbd.co
702-201-6450
corp@greycloaktech.com
cbd.co
https://resource.globenewswire.com/Resource/Download/582c34b4-1662-404c-8c4f-33d81a2233f2?size=1
HUGE INMG NEWS! TA verifies float of 172,611,602 that is locked and cannot be diluted until summer 2018 at the earliest. Share structure was updated yesterday!
The first potential round of dilution would be June 25th, 2018. That's exactly one year from when the restricted shares used to purchase a minority stake in Night Flight were issued. From the PR:
The Company’s equity interest in Night Flight, Inc. was purchased with a combination of cash and through the issuance of restricted common shares of the Company’s stock and was completed on June 25, 2017.
http://www.otcmarkets.com/stock/INMG/news/Innovativ-Media--INMG--Acquires-Minority-Stake-in-Night-Flight?id=163182&b=y
The PREFERRED B SERIES shares he used on October 18, 2017 were exercised under a lock-up agreement to redeem the shares and remove any uncertainty regarding long term dilution. Dilution cannot happen again because they are no longer available.
http://www.otcmarkets.com/stock/INMG/news/Innovativ-Media--INMG--Redeems-Series-B-Preferred-Shares?id=172123&b=y
BECAUSE OF RULE 144, THE NOTE HOLDER CANNOT SELL THEM UNTIL OCTOBER 2018, THEREFORE, WE WILL REMAIN WITH A FLOAT OF 172,611,602 SHARES UNTIL JUNE 25, 2018 AT THE EARLIEST!!!
https://www.sec.gov/reportspubs/investor-publications/investorpubsrule144htm.html
Share Structure
Market Value $3,760,331 a/o Dec 29, 2017
Authorized Shares 500,000,000 a/o Jan 02, 2018
Outstanding Shares 291,724,670 a/o Jan 02, 2018
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 172,611,602 a/o Jan 02, 2018
Par Value Not Available
https://www.otcmarkets.com/stock/INMG/profile
$ADAC On alert this week. Put this one on your radar. Take a look at their informative website. https://www.adamatechnologies.com
EHVVF news Ehave Launches Baseline Concussion Assessment Tool on Ehave Connect
PR Newswire PR Newswire•January 3, 2018
TORONTO, Jan. 3, 2018 /PRNewswire/ -- Ehave, Inc. (EHVVF), a healthcare company dedicated to empowering the mental health community with next-generation digital solutions, today announced that the Company has created a baseline concussion assessment tool that is now available on Ehave Connect, a digital "App Store" designed to enhance access to a broad array of content offered by Ehave and its growing roster of mental healthcare partners. The test will record baseline concussion symptoms using validated cognitive assessments and, via the robust Ehave Core Platform, provide extensive information about the athlete's history with concussions upon repeat assessment following acute injury. The platform can also be used to track treatment progress to help guide return-to-sport and return-to-school strategies.
As many as 1.6-3.8 million sports-related concussions occur in the U.S. each year and it is estimated that up to 50% of concussions go unreported. Factors contributing to the underreporting of concussive injury include gaps in knowledge concerning concussion symptoms, beliefs that the injury is not serious, and unwillingness to be removed from competition. Despite this underreporting, concussion incidence rates have been increasing in the past two decades.
Baseline concussion tests are an important piece in concussion management, and an area that is uniquely suited to the benefits of Ehave's mental health platform. Baseline assessments are typically taken as a preventative measure prior to a sport season. The same test can be taken again by the athlete/caregiver after an injury to provide comparative pre- and post-injury scores. Comparing post-injury test scores of an individual to their own baseline test scores as opposed to the general population is considered best practice.
Prateek Dwivedi, CEO of Ehave, said, "Mild traumatic brain injury (mTBI), or concussion, is the most common type of traumatic brain injury and is part of the target group of mental and cognitive conditions that Ehave is currently focused on. Initially, we plan to focus marketing of our baseline concussion test on school boards and amateur sports leagues where the need is greatest. Separately, Ehave is currently exploring Ehave Connect to manage treatment plans and track patient outcomes as part of a clinical trial to evaluate medical cannabis's potential ability to provide relief to persons suffering from post-traumatic stress disorder ("PTSD"). This use of our platform may be extended to mTBI, where early research has indicated the potential utility of cannabinoids in the treatment of both acute and chronic traumatic brain injury."
About Ehave, Inc.
Ehave is empowering the mental healthcare community with a next-generation of data-rich tools designed to improve patient management, diagnosis and treatment. With Ehave Connect, Ehave's mental health informatics platform, clinicians can make objective, data-driven decisions while keeping patients informed and engaged throughout their mental healthcare journey. Ehave Connect offers a powerful set of core features that integrate with a growing selection of tools and applications developed by Ehave and its leading partners, including Multi-Health Systems ("MHS"), a leading publisher of psychological assessments. Ehave is initially focused on improving the standard of care in attention deficit hyperactivity disorder ("ADHD"), through its collaboration with the Hospital for Sick Children ("SickKids"). Ehave Connect is also being utilized to advance the validation and optimization of medical cannabis, through its collaboration with MedReleaf. For more information, visit https://www.ehave.com/.
Forward-Looking Statement Disclaimer
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company's research, manufacturing and other development efforts; (ii) the Company's ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company's products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company's industry and introduction of competing products; (vi) the Company's ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is contained under the heading "Risk Factors" in Ehave, Inc.'s Registration Statement on Form F-1 filed with the Securities and Exchange Commission (SEC) on September 24, 2015, as amended, which is available on the SEC's website, http://www.sec.gov.
CBIS News -- Cannabis Science Negotiates With Crown Baus Capital Corp (OTC: CBCA) for Future Blockchain Cryptocurrency ICO Growth While Adding Strength to its Pharmacy Openings and Pharmaceutical Drug Development Programs
GlobeNewswire•January 3, 2018
IRVINE, CA, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC Pink: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce its intent to partner with its sister company, Crown Baus Capital Corporation (OTC Pink: CBCA), to strengthen CBIS’ planned blockchain crypto-currency ICO offering.
Details of the CBIS and CBCA cryptocurrency blockchain arrangement are expected to be finalized and announced shortly. Mr. Dabney and his management team are working to make the best deal structure for all shareholders involved, including a CBIS equity stake in CBCA or vice versa. Working together is in the best interests of both CBCA and CBIS as this type of relationship leverages the capabilities, experience, and expertise of both Companies. CBIS seeks to link the capital structure of CBCA with its upcoming asset backed blockchain cryptocurrency ICO, as well as leverage the pharmacies and pharmaceutical drug development programs currently underway as well as in the robust pipeline.
Crown Baus Capital Corp., (www.crownbaus.com) is a global, acquisition-based conglomerate targeting opportunities in drug development, high-tech incubation, entertainment & media, education, and financial services. CBIS is looking to leverage CBCA’s capital structure to access even more additional strength to fast-track the Company’s growth plans for its pharmacy openings and pharmaceutical drug development programs which are consistent with the Company’s aggressive global business development strategy that now will include a proposed asset backed blockchain cryptocurrency ICO offering.
“Alongside our Lawyers and Accountants, we have been working very hard behind the scenes to finish updating the Crown Baus financials and audit to get Crown Baus current and up to date with its SEC/FINRA filings with audited full and transparent disclosures. Now that we have completed the bulk of the work, we are pretty much ready to begin the audit and complete filing of all outstanding financials and exhibits to bring CBCA current on all financials with the SEC/FINRA, This needs to happen regardless and we are in the middle of doing it, so I expect this auditing process to be completed and filed early in 2018,” stated Mr. Raymond C. Dabney, President & CEO, Co-Founder of both Cannabis Science Inc., (CBIS) and Crown Baus Capital Corp., (CBCA).
“These types of agreements closely align with the interests of CBCA and CBIS in drug development and financial security, thus enabling each company to focus on its particular area of expertise. I believe this is a very smart move for a number of reasons, considering the size of the pharmaceutical drug development industry and the newly formed crypto-currency blockchain industry, so we are looking to add two or three engines to this blockchain thing and see what it does. We most certainly believe it will actually put us in a much stronger position to move our projects forward at a much faster growth rate. With California alone having the world’s sixth largest economy with a GDP of 2.5 trillion dollars, this has opened up a very large market for both Companies in our own backyard. I expect the shareholders of CBCA and CBIS to see an increased book value as a direct result of this agreement. Particularly, this relationship will help CBIS to focus on pharmaceutical drug development and will allow CBCA to focus on finance, as well as on future acquisition deals,” stated Mr. Raymond C. Dabney.
CBIS will officially open the first two Cannabis Science Pharmacies in the city of Los Angeles and the greater San Fernando Valley area of Los Angeles. Both pharmacies are scheduled to open January 2018. These pharmacies are looking to meet the expected increased demand in the Los Angeles market from the much-anticipated, new California recreational market influx. These pharmacies will lead to increased access to high quality over the counter pharmaceuticals, nutraceuticals, and cosmeceuticals. Opening these first two pharmacies in Los Angeles is a huge step for Cannabis Science and it will accelerate the Company’s aggressive pharmaceutical expansion plans in the Los Angeles area, throughout California, and eventually nationwide.
Cannabis Science Proposed Asset Backed Blockchain Crypto-Currency ICO
This January 2018 Cannabis Science Inc. plans pre-launch sales of its own proprietary blockchain and will commence ICO trading with a unique three symbol trading symbol on a number of blockchain currency exchange markets after pre-launch sales have completed with similar Bitcoin type ICO trading to follow. The Cannabis Science blockchain white papers are being finalized now for January 2018 release.
From Wikipedia:
Initial coin offering (ICO) is a controversial means of crowdfunding via use of cryptocurrency,[1][2] which can be a source of capital for startup companies.[3] In an ICO, a percentage of the newly issued cryptocurrency is sold to investors in exchange for legal tender or other cryptocurrencies such as Bitcoin or Ethereum.
Early token sales were held by Mastercoin in July 2013 and Ethereum and Karmacoin in 2014, but "mainstream" ICOs began with messaging app developer Kik in September 2017. By November 2017 there were around 50 offerings a month.
ICOs may fall outside existing regulations or may need to be regulated[4][5] depending on the nature of the project, or banned altogether in some jurisdictions, such as China and South Korea. [6][7]
A blockchain,[1][2][3] originally block chain,[4][5] is a continuously growing list of records, called blocks, which are linked and secured using cryptography.[1][6] Each block typically contains a hash pointer as a link to a previous block,[6] a timestamp and transaction data.[7] By design, blockchains are inherently resistant to modification of the data. The Harvard Business Review describes it as "an open, distributed ledger that can record transactions between two parties efficiently and in a verifiable and permanent way."[8] For use as a distributed ledger, a blockchain is typically managed by a peer-to-peer network collectively adhering to a protocol for validating new blocks. Once recorded, the data in any given block cannot be altered retroactively without the alteration of all subsequent blocks, which requires collusion of the network majority.
Blockchains are secure by design and are an example of a distributed computing system with high Byzantine fault tolerance. Decentralized consensus has therefore been achieved with a blockchain.[9] This makes blockchains potentially suitable for the recording of events, medical records,[10][11] and other records management activities, such as identity management,[12][13][14] transaction processing, documenting provenance, food traceability[15] or voting.[16]
The first blockchain was conceptualized in 2008 by an anonymous person or group known as Satoshi Nakamoto and implemented in 2009 as a core component of bitcoin where it serves as the public ledger for all transactions.[1] The invention of the blockchain for bitcoin made it the first digital currency to solve the double spending problem without the need of a trusted authority or central server. The bitcoin design has been the inspiration for other applications.[1][3]
CBIS news very likely today should break .13 this week
VATE and SIPC two front loaded plays. Be real careful if your wanting to trade those tickets. Rug about to be pulled on both. Cheers
OTTV.0016 BOTTOM, TIME TO LOAD JUST SAYING!
LIBE. Breakout. 14 Mill os. 0.015.
https://www.cnbc.com/2017/12/07/trump-will-start-infrastructure-push-in-january-white-house-officials-say.html
$GCEI ON HIGH ALERT> January Effect
https://www.investopedia.com/terms/j/januaryeffect.asp
GROSSLY UNDERVALUED
www.globalcleanenergy.net/
Go GREEN with Global Clean Energy a Enviromentally Friendly Waste Tires to Fuel & Algae to Products Company
glta
BLOK the BEST blockchain stock on the BLOCK!!!!!!!!!!
https://investorshub.advfn.com/Block-One-Capital-Inc-TSXV-BLOK-32779/
BLOK - huge breakout today!!! Already 43% up in germany!!!
************************************ BLOK ***************************************
https://investorshub.advfn.com/Block-One-Capital-Inc-TSXV-BLOK-32779/
$GCEI ON HIGH ALERT> ADDITIONAL NEWS/UPDATES EXPECTED AT ANYTIME NOW.
#NEWS #3RD #QUARTER #UPDATE: (below)
https://www.altenergymag.com/content.php?post=27486
#Global #Budding #Superfood #Algae could spawn a mkt worth close to $47 #BILLION by 2023 (below)
http://news.algaeworld.org/2017/08/algae-go-super/
Go GREEN with Global Clean Energy a Enviromentally Friendly Waste Tires to Fuel & Algae to Products Company.
http://www.globalcleanenergy.net/
GO $GCEIIIIII
glta
$GCEI ON HIGH ALERT>THE SHAREHOLDERS AREN'T GOING DOWN WITHOUT A FIGHT.THEY WILL PREVAIL. $$$$
GO $GCEI
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136982742
LIBE. MJ infrastructure. The "Wall". Pipelines.
https://www.cnbc.com/2017/12/07/trump-will-start-infrastructure-push-in-january-white-house-officials-say.html
APRU .0021 MJ CBD play! Doing business with MJNA! Broke out Tues!
APRU is beginning a run. Word getting around. GET IN!!!
CEO Tweeted on Friday they shipped order to MJNA. He says, "Great year...STAY TUNED" for more news!!
Final delivery for the year! More Chews to Kannaway! Its been a great year so stay tuned. #doinitright $APRU $MJNA
— Apple Rush Company (@RealAPRU_NEWS) December 29, 2017
I know you want more, but new revenue stream coming soon. Waiting for a document to finalize fins. 2018 will be great. $APRU #doinitright pic.twitter.com/IhucAVZ1mO
— Apple Rush Company (@RealAPRU_NEWS) December 29, 2017
IDVV- California cannabis company in the middle of the California pot Gold rush. only 1.8 million shares. LAST TRADE .115 UP 15%. Undiscovered but not for long. Price Target 1.00 where it traded only a few months ago imo.
$LIBE. 14 Mill os. JV with Bravatek Solutions announced on Fri.
Trump train.
https://www.cnbc.com/2017/12/07/trump-will-start-infrastructure-push-in-january-white-house-officials-say.html
$MJLB !! can we see .01 today ~~ 9 mil float
$BEGI BITCOIN #BLOCKCHAIN CO 300,000 FLOAT
About Us
BlackStar Enterprise Group, Inc. (BlackStar, the Company) is a publicly traded specialized merchant banking firm, facilitating joint venture capital to early stage revenue companies. BlackStar’s shares trade on the OTC QB (BEGI). The Company is focused on blockchain technology. BlackStar intends to gain exposure to the blockchain ecosystem through targeted joint ventures in the sector. The primary focus is on the distributed ledger security features and peer-to-peer (P2P) global equity trading arena. While remaining compliant with current SEC disclosure and reporting guidelines Blackstar is conducting an in-depth analysis for its involvement in Crypto related ventures. BlackStar, (BEGI) is one of a few publicly traded blockchain focused companies listed on the OTC Markets.
BlackStar Enterprise Group intends to leverage its experience in the traditional world of public finance, including securities, options, registrations and SEC compliance, into working with select organizations supporting the development and implementation of new technologies in the crypto currency world. To facilitate this process, BlackStar is establishing an advisory board with applicable technical and practical experience. BlackStar is also becoming an advocate and supporter of P2P equity trading on a distributed decentralized ledger which provides investment exposure to the rapidly growing blockchain ecosystems.
With the demise of the OTC small cap brokerage firm, today's emerging companies have little choice but to raise private equity, crowdfund, or participate with the (up to now) unregulated cryptocurrency market over the Internet. In turn, these investment strategies limit the private investor to high-risk, non-liquid equity ownership with little or no diversification and no regulation or accountability.
BlackStar is currently seeking joint venture investments in private, commercial-stage businesses with focus on blockchain technologies within the industry sectors covered by its collective experience, including:
finance
healthcare
technology
media & telecommunications
energy, clean technology & renewables
industrials
business services
BlackStar will initially control and manage each venture.
The Company’s venture development will have a planned path to liquidity in a three-year +/- timeframe.
BlackStar’s acts as a merchant bank providing access to capital for companies involved in crypto-equities with P2P trading. BlackStar will facilitate these companies, through majority controlled joint ventures with our subsidiary Crypto Equity Management Corp., therefore offering our shareholders entry into the revolutionary crypto equity/cybersecurity space. BlackStar’s publicly traded stock may be a conduit for the investor into blockchain related industry and private companies supporting its philosophies while providing a diversified and potentially liquid investment for the public investor.
http://www.blackstarenterprisegroup.com/about-us/ ;
$SGDH MARIJUANA $BEGI blockchain will Run!!
$PMCB PharmaCyte Biotech Meets with Oncology Advisory Board PMCB
Business Wire Business WireDecember 11, 2017Comment
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--
PharmaCyte Biotech, Inc. (PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it recently met with its Oncology Advisory Board, which was formed to assist in optimizing and finalizing the clinical protocol and other clinical trial-related matters for PharmaCyte’s clinical trial in patients with locally advanced, non-metastatic, inoperable pancreatic cancer (LAPC).
Representatives from the Advisory Board and PharmaCyte participated in an in-depth teleconference and discussed a variety of clinical trial-related matters, most of which were designed to optimize the trial protocol and develop strategies to ensure that patient enrollment in the clinical trial can be maximized.
Oncologists from several major institutions across the U.S. are participants on the Advisory Board. These institutions include the Beth Israel Deaconess Medical Center, Duke University, the Mayo Clinic, the Memorial Sloan Kettering Cancer Center, Northwestern University, the University of California, San Francisco, the University of Southern California and the Cleveland Clinic.
Kenneth L. Waggoner, PharmaCyte’s Chief Executive Officer, stated, “We are extremely grateful to those prominent oncologists who have agreed to join our Oncology Advisory Board to assist us in finalizing our clinical trial protocol and in sharing their views on how best to achieve our goal of making our therapy available to those patients who desperately need an effective treatment for LAPC. We received invaluable input from these experts in pancreatic cancer that should allow PharmaCyte to enter the clinic with the best possibility for success.”
About PharmaCyte Biotech
PharmaCyte Biotech is a clinical stage biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed.
PharmaCyte’s therapy for cancer involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active or “cancer-killing” form. For pancreatic cancer, these encapsulated cells are implanted in the blood supply to the patient’s tumor as close as possible to the site of the tumor. Once implanted, a chemotherapy drug that is normally activated in the liver (ifosfamide) is given intravenously at one-third the normal dose. The ifosfamide is carried by the circulatory system to where the encapsulated cells have been implanted. When the ifosfamide flows through pores in the capsules, the live cells inside act as a “bio-artificial liver” and activate the chemotherapy drug at the site of the cancer. This “targeted chemotherapy” has proven effective and safe to use in past clinical trials and results in no treatment related side effects.
PharmaCyte’s therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes involves encapsulating a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box® technology. Once the encapsulated cells are implanted in a diabetic patient, they will function as a “bio-artificial pancreas” for purposes of insulin production.
Safe Harbor
This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans," "will," "outlook" and similar expressions. Forward-looking statements are based on management's current plans, estimates, assumptions and projections, and speak only as of the date they are made. We undertake no obligation to update any forward-looking statement because of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements due to the impact of numerous risk factors, many of which are discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the Securities and Exchange Commission.
More information about PharmaCyte Biotech can be found at www.PharmaCyte.com. Information may also be obtained by contacting PharmaCyte’s Investor Relations Department.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171211005266/en/
Contact:
Investor Relations:
PharmaCyte Biotech, Inc.
Dr. Gerald W. Crabtree
Investor Relations Department
917.595.2856
Info@PharmaCyte.com
$BTC.X $BCH.X $BTG.X $ETH.X $XRP.X $LTC.X $XMR.X $DASH.X $TRX.X $XEM.X $ADA.X $XLM.X $SALT.X
Charts 1/2/18
TA Video
NVTQF ~the most undervalued BLOCKCHAIN stock, NEW DD!
Novateqni is a public company listed on the TSX Venture Exchange under the symbol “NTQ” and the OTCQB market under the symbol “NVTQF”. Novateqni develops and supplies solutions for the Biometrics, Payments, Elections, and Internet of Things Sectors. Using leading technologies such as blockchain and biometrics, Novateqni is focussed on creating intellectual property and value through innovation. Management has a long history of developing and supplying products to clients such as the US Navy, IBM, Honeywell, NEC, Vodacom, MTN, the United Nations Development Program, and the Tobacco Control Commission in Malawi.
WEBSITE: http://novateqni.com/
Fact Sheet: http://novateqni.com/wp-content/uploads/2017/10/factsheetv2.pdf
1) NVTOF has 35 million shares. CEO holds 46% of them. Float about 17 million.
http://novateqni.com/2017/11/07/novateqni-announces-shares-for-debt-settlement-with-ceo/
2) NVTQF has 9 different products. A few of them are patented BLOCKCHAIN products.
http://novateqni.com/products/
3) They have clients UNITED NATION, IBM, US Navy, Honeywell, Vodacom, MTN....
4) They have offices around the world. USA, Canada, Hong Kong, South Africa...
5) They generate revenue as well.
6) Many blockchain stocks have no any patented products and not generating even 1 dollar revenue and trading at multi-dollars level.
Most recent news!
1) Oct 31 - NovaTeqni And Novus To Showcase New Blockchain Capable Census Devices - https://web.tmxmoney.com/article.php?newsid=7753950684321878&qm_symbol=NTQ
2) Oct 5 - NovaTeqni Receives Request For Proposal For Blockchain Solution - https://web.tmxmoney.com/article.php?newsid=8163044844565320&qm_symbol=NTQ
3) Oct 4 - NovaTeqni to Incorporate Blockchain into Farmers Management System and Announces Prototype Completion of Finger Print Door Access System with Virtual Reception and Time and Attendance Functionality - https://web.tmxmoney.com/article.php?newsid=6069527196594259&qm_symbol=NTQ
4) Sept 27 - NovaTeqni Currently Reviewing Adoption of Block Chain Technologies and Provides Corporate Update - https://web.tmxmoney.com/article.php?newsid=6427069689282787&qm_symbol=NTQ
For me, NVTQF is the most undervalued blockchain stock. Don't lose this multi-bagger opportunity in my opinion.
I am long.
Read, check and make your own DD.
$TXHD ABOUT TO RUN..0004X.0005. Dilution is over. Look for pennyland shortly.
$MTP $BURG $TRVN $TEUM $GROW $NETE $LTEA $NOG $RENN $SRNE $IGC $TRX $PLG Charts 1/2/18
TA Video
Followers
|
8281
|
Posters
|
|
Posts (Today)
|
36
|
Posts (Total)
|
2348141
|
Created
|
12/20/05
|
Type
|
Free
|
Moderator MOMO | |||
Assistants i_like_bb_stock Cube balamidas |
*** PURPOSE of the BOARD is to alert both penny and big board stocks which are breaking out in play.
Furthermore, this board provides an open forum for both experienced and new traders alike to shares their stock picks, opinions and experiences.
At one time or another, we were all new to trading and looking for a place to learn and understand the market, which is one of the main reasons this board was created.
This forum provides new investors a place to learn and feel comfortable doing it.
*** ALERTS are based on stocks that show an acceleration of price or volume; showing signs of reversing based on their chart and volume are not suitable for all investors.
Due to the increased volatility and high risk exposure when trading penny stocks, it is possible to lose your entire investment.
Taking profits, due diligence and preservation of your initial investment is key and must be taken into consideration.
All stocks mentioned are welcome herr and range from pennies to the big boards and everything in between.
Do your own due diligence before investing and never trade more than you can afford to lose.
Traders should plan their exits before they trade and take profits the way up.
We are here to help -- let us know if we can be of any assistance.
*** A MUST HAVE for TRADERS http://www.equityfeed.com/
IMPORTANT / USEFUL LINKS
SHO LIST: http://www.nasdaqtrader.com/aspx/regsho.aspx
BUYINS.NET: http://www.buyins.net/
POST S-8 PLAYS: http://www.investorshub.com/boards/board.asp?board_id=1605
TOXIC FILINGS: http://www.investorshub.com/boards/board.asp?board_id=4318
REVERSE SPLITS: http://www.investorshub.com/boards/board.asp?board_id=3017
DEATH DROP: http://www.investorshub.com/boards/board.asp?board_id=3341
PRESS RELEASES:http://home.businesswire.com/portal/site/home/index.jsp?front_door=true
1512g Filings - http://1512g.com/
American Stock Exchange - http://www.nyse.com/attachment/amex_landing.htm
Authorized Shares for Nevada and Other States - http://www.authorized-shares.com/
Barrons - http://online.barrons.com/public/main
BioHealth - http://www.biohealthinvestor.com/
BioMed - http://biomedreports.com/
BioSpace - http://www.biospace.com/
Bloomberg - http://www.bloomberg.com
Business News - http://www.bloomberg.com
Business News - http://www.reuters.com/finance/markets
Business News Portal - http://www.businesswire.com/portal/site/home/
BusinessWeek - http://www.businessweek.com/
Candlesticks - www.candlesticker.com/Default.asp
Chart Analysis - www.stockcharts.com/school/doku.php
Chart Video Lessons - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46647251
Charts - http://bigcharts.marketwatch.com/avatar.asp
Charts - http://chartpatterns.com/
Charts - http://stockcharts.com/
Charts - http://www.incrediblecharts.com/technical/candlesticks.htm
China Business News - http://www.chinadaily.com.cn/bizchina/index.html
China Business News - http://www.xinhuanet.com/english2010/business/index.htm
China Technology News - http://www.chinatechnews.com/
Clinical Trials - http://www.clinicaltrials.gov/
CNBC - http://www.cnbc.com
CNNMoney.com - http://www.money.cnn.com/
Corporate Bankruptcy - http://www.sec.gov/investor/pubs/bankrupt.htm
Corporate Records Search - http://www.coordinatedlegal.com/SecretaryOfState.html
Corporate Records Search - http://www.searchsystems.net/list.php?nid=398
CUSIP number - http://activequote.fidelity.com/mmnet/SymLookup.phtml
DD Amanda - http://ddamanda.com/Members/AmandaChartStart.php
DD Machine - http://www.ddmachine.com/
Deregistering - http://www.aaii.com/commentary/articles/200601_stockstrategies.cfm
Dividends - http://www.dividenddetective.com/
Document Research - http://www.10kwizard.com/main.php
Earnings - http://www.earningswhispers.com/calendar.asp
Education - http://www.investopedia.com/?viewed=1
Email Address Verifier - http://verify-email.org/
EYE ON THE FDA - http://www.eyeonfda.com/
FINRA Daily Short List - www.regsho.finra.org/regsho-Index.html
Floats - http://investorshub.advfn.com/boards/board.aspx?board_id=15223
Fool.com - http://www.fool.com
Forbes - http://www.forbes.com/home_usa
Form 4 Filings - http://www.secform4.com/index.php
Google News Business - http://news.google.com/?ned=us&topic=b
Google News Home - http://news.google.com/
Holiday Schedule for Stock Markets - http://www.allstocks.com/html/stock_markets_holidays.html
High Short Interest Stocks - http://www.highshortinterest.com/
Insider Buy & Sell Info - http://www.insidercow.com/latestFillings/buyByCompany
Investing Glossary - http://www.investorwords.com/
Investopedia - http://www.investopedia.com/?viewed=1
Investors Business Daily - http://www.investors.com
Investor Words - http://www.investorwords.com/
Knobias - http://www.knobias.com/individual/public/quote.htm
Level 2 Video Tutorial - http://stockhideout.com/images/flash/level.html
Low Float Stocks - http://www.lowfloat.com/
MarketWatch.com - http://www.marketwatch.com/
Message, Blog & Twitter Postings - http://www.thelion.com
MicrocapMarkets NASDAQ <$5 - http://www.microcapmarkets.com/data_main_nav.jsp?market=NASDAQ
MicrocapMarkets OTCBB - http://www.microcapmarkets.com/data_main_nav.jsp?market=OTCBB
Mining - http://www.miningmx.com/
MSN Money Central - http://www.moneycentral.msn.com/investor/home.asp
Multicollinearity - www.stockcharts.com/help/doku.php
Mutual Fund Facts About Individual Stocks - http://www.mffais.com/
Naked Shorting - www.businessjive.com/
NASDAQ Stock Market - http://www.nasdaq.com/
NASDAQ/NYSE/AMEX Stock Info - www.secfilings.com/
Natural Resources News & Commentary - http://www.resourceinvestor.com/Pages/default.aspx
New York Stock Exchange - http://www.nyse.com/home.html
OTCBB Daily List - http://www.otcbb.com/dailylist/
Patterns - http://thepatternsite.com/
Pinksheets Stock Info - www.otcmarkets.com/pink/index.jsp
Platform - http://www.quotetracker.com/
Precious Metals - http://www.kitco.com/
Press Releases - http://www.prnewswire.com/news-releases/
REG SHO List - www.regsho.com/tools/short_list.php
Regional Bank List - http://www.bullsector.com/regionalbanks.html
Reverse Phone & Address - http://www.whitepages.com/reverse-lookup
Reverse Mergers - http://www.gopublic.com/reversemerger.html
Reverse Merger Report - http://reversemerger.dealflowmedia.com
Reverse Splits - http://investorshub.advfn.com/boards/board.aspx?board_id=3017
Screener - http://clearstation.com
Screener - http://smallcapcenter.com
Searching Blogs, News, etc. - http://www.icerocket.com/
SEC - http://www.sec.gov
SEC Filings - http://www.edgar-online.com/
SEC Filings - http://www.sec.gov/edgar/searchedgar/companysearch.html
SEC Filings - http://www.secinfo.com
SEC Form Types and Definitions - http://learn.westlawbusiness.com/support/formtypes.html
Secretary of State Sites - All states: http://www.coordinatedlegal.com/SecretaryOfState.html
Seeking Alpha BioTech Stocks - http://www.seekingalpha.com/sector/biotech
Shell Stocks - http://www.shellstockreview.com
SHO Threshold List - http://www.nasdaqtrader.com/Trader.aspx?id=RegSHOThreshold
Short Stocks - http://shortsqueeze.com/
Stock Chart Patterns - www.trending123.com/patterns/index.html
Stock Promotions - www.stockpromoters.com
Stock Promotions - www.stockreads.com/
Stock Research - http://www.stockhouse.com
Stock Scanning - http://bigcharts.marketwatch.com/markets/screener.asp?exchange=118&screen=1&x=15&y=18
Stock Scanning - http://clearstation.etrade.com/cgi-bin/events?Cmd=techev
Stock Scanning - http://markets.usatoday.com/custom/usatoday-com/screener/screener.asp
Stock Scanning - http://screen.yahoo.com/stocks.html
Stock Scanning - http://stockcharts.com/def/servlet/SC.scan
Stock Scanning - http://www.acmechart.com/
Stock Scanning - http://www.americanbulls.com/
Stock Scanning - http://www.barchart.com/
Stock Scanning - http://www.prophet.net/scans/index.jsp
Stock Scanning - http://www.smallcapcenter.com/tools_technicalSearch.asp?page=ANALYTICSSEARCH_IN.ASP
Stock Scanning - http://www.stockciphering.com/index.htm
Stock Scanning - http://www.stockfetcher.com/
Stock Scanning - http://www.stockscores.com/index.asp
Stock Scanning - http://www.stockworm.com/help/tours/stock-screener.html;jsessionid=aEg_MdzO2SH9
Stock Scanning - http://www2.barchart.com/
Technical Analysis - http://stockta.com/
Technical Indicators/Overlays - www.stockcharts.com/school/doku.php
TheStreet.Com - http://www.thestreet.com/
Trading Halts - http://www.nasdaqtrader.com/Trader.aspx?id=TradeHalts
Trading Platform - www.equityfeed.com
Trading Stations - http://www.tradingcomputers.com/index.html
Transfer Agent Contact Information - http://investorshub.advfn.com/boards/board.aspx?board_id=10067
Transfer Agents in the United States - http://www.stocktransfer.com/index.cfm?action=about.network.transferAgents
Translation Tool - http://www.verbatimsolutions.com/freetranslation.php
USAToday Business - http://markets.usatoday.com/custom/usatoday-com/html-markets.asp
Complete List of Transfer Agents in the United States:
http://www.stocktransfer.com/index.cfm?action=about.network.transferAgents
Stock Market Holiday Schedule
http://www.allstocks.com/html/stock_markets_holidays.html
RULES OF THE BOARD~
*** NO PERSONAL ATTACKS or VULGARITY WILL BE TOLERATED!!!
DISCLAIMER:
Opinions expressed on this board are just opinions. We are not licensed brokers.
Trading strategies discussed on this board are often high risk and are not suitable everyone.
If you consistantly lose money in the market, you may wish to seek the advice of a licensed securities professional.
No one is responsible for your gains or losses in the market except YOU.
Following stocks, strategies discussed on this board, you may LOSE ALL YOUR MONEY.
Please weigh the strategies discussed here carefully against what you are willing to risk.
Please do due diligence before buying or selling ANY SECURITY in the open market; are no guarantees.
TRADE WELL & REMEMBER TO TAKE PROFITS on THE WAY UP!
GOOD LUCK!
*** FOLLOW OUR ALERTS ON TWITTER ***
http://twitter.com/#!/pennystockmomo
*** FOR EARLY ALERTS SIGN UP FOR THE BREAKOUT TRADERS E-MAIL LIST ***
http://investorshub.advfn.com/boards/chairmail_sub.asp?board_id=4929
Posts Today
|
36
|
Posts (Total)
|
2348141
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |